Artificial intelligence (AI) has potential to revolutionize radiology, yet current solutions and guidelines are predominantly focused on adult populations, often overlooking the specific requirements of children. This is important because children differ significantly from adults in terms of physiology, developmental stages, and clinical needs, necessitating tailored approaches for the safe and effective integration of AI tools. This multi-society position statement systematically addresses four critical pillars of AI adoption: (1) regulation and purchasing, (2) implementation and integration, (3) interpretation and post-market surveillance, and (4) education. We propose pediatric-specific safety ratings, inclusion of datasets from diverse pediatric populations, quantifiable transparency metrics, and explainability of models to mitigate biases and ensure AI systems are appropriate for use in children. Risk assessment, dataset diversity, transparency, and cybersecurity are important steps in regulation and purchasing. For successful implementation, a phased strategy is recommended, involving early pilot testing, stakeholder engagement, and comprehensive post-market surveillance with continuous monitoring of defined performance benchmarks. Clear protocols for managing discrepancies and adverse incident reporting are essential to maintain trust and safety. Moreover, we emphasize the need for foundational AI literacy courses for all healthcare professionals which include pediatric safety considerations, alongside specialized training for those directly involved in pediatric imaging. Public and patient engagement is crucial to foster understanding and acceptance of AI in pediatric radiology. Ultimately, we advocate for a child-centered framework for AI integration, ensuring that the distinct needs of children are prioritized and that their safety, accuracy, and overall well-being are safeguarded.
Background Uterine rudiments are present in up to 50% of Mayer-Rokitansky-Küster-Hauser syndrome casesObjective: To describe the clinical course of cases of uterovaginal agenesis with symptomatic and asymptomatic Mullerian remnants This series highlights the importance of early diagnosis and individualized surgical management. Case or Series Two of the four cases presented with cyclic pelvic pain associated with functional rudimentary uterine horns and secondary endometriosis. Imaging (ultrasound, MRI, and CT) confirmed uterine abnormalities, with findings of uterine agenesis, rudimentary uterine horns, and associated renal malformations in one case. All patients underwent diagnostic laparoscopy, and three underwent excision of rudimentary uterine horns. Histological findings included adenomyosis and endometriosis in symptomatic patients. Comments Functioning uterine rudiments can cause cyclical pain and promote endometriosis. Early diagnosis and comprehensive follow-up are key to long-term prognosis.
OBJECTIVES:To characterize the magnetic resonance imaging (MRI) lesion dynamics, comorbidities, predictors of relapse, and outcomes in anti-γ-aminobutyric acid type A receptor (GABAAR) encephalitis, and assess the utility of LIM-domain-only-protein 5 (LMO5) antibodies as tumor markers. METHODS:GABAAR antibodies were confirmed by 2 techniques in serum or cerebrospinal fluid. Long-term outcomes were defined as good (modified Rankin scale, mRS = 0-1) or poor (mRS 2-5) at ≥12 months. LMO5 antibodies were assessed by cell-based assays and Western blot. RESULTS:Thirty-three patients were identified (4 children, 29 adults; median age, 5.5 and 60 years; 61% male). Ten patients (10/32, 31%) had concurrent systemic autoimmunity. Adults presented with seizures and cognitive/behavioral symptoms, often with thymoma, gastrointestinal, or other tumors (18/33, 55%), whereas children frequently had seizures and ataxia with cerebellar MRI lesions. Multifocal T2/fluid-attenuated inversion recovery hyperintensities were present at onset in 23 of 31 (74%) or developed later in those with absent or single lesions. Lesions showed dynamic changes, suggesting ongoing inflammation even without clinical correlate. Relapses occurred in 17 of 31 (55%, all adults) and were associated with older age (p = 0.02) and lack of second-line immunotherapy (p = 0.02). Four patients (4/33, 12%) died. After a 32.5-month median follow-up, 9 of 20 (45%) had persistent cognitive deficits, and 6 of 20 (30%) had a poor outcome, which was associated with relapses (p = 0.04). LMO5 antibodies were absent in patients and controls. INTERPRETATION:Anti-GABAAR encephalitis shows age-dependent presentations, most commonly seizures. MRI reveals dynamic changes consistent with an ongoing "clinically silent" inflammation. Relapses and cognitive sequelae are common and associate with not receiving second-line immunotherapy. LMO5 antibodies lack tumor-predictive value. ANN NEUROL 2026;100:139-150.
Introducción: El secuestro pulmonar es una malformación congénita del sistema respiratorio, principalmente del tracto respiratorio inferior, que se caracteriza por presentar irrigación por una arteria aberrante y no presentar comunicación con el árbol traqueobronquial. Caso: Paciente varón de 4 meses con antecedentes de hospitalizaciones previas por infecciones respiratorias, cuyo cuadro actual inicia con fiebre y distrés respiratorio, que no mejora con tratamiento antibiótico, broncodilatadores y soporte ventilatorio. Con ayuda de tomografía y su reconstrucción tridimensional, se confirma secuestro pulmonar. Se observó la presencia de dos arterias aberrantes que se originan del tercio inferior de la aorta descendente torácica que se dirige hacia el lóbulo pulmonar inferior izquierdo y el drenaje venoso pulmonar que se dirige hacia la unión de la vena cava superior con la aurícula derecha. Con el diagnóstico claro, se concluye manejo quirúrgico, que se realizó satisfactoriamente, y el diagnóstico se confirma por patología. Conclusión: El secuestro pulmonar intralobar asociado a drenaje anómalo parcial de venas pulmonares es una entidad rara que se trata quirúrgicamente.